|
|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
| |
|
Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new
trends and marketing opportunities, as well as highlighting the latest innovations in this
dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.
We're also on Twitter! Follow us @PMPSmag
Read
our publications on the go in the Samedan app for phones and tablets. You
can download issues for offline reading, and our archives go as far back
as 2008! Download for free on the App Store, GooglePlay, or Amazon.   
|
|
|
|
|
|
 |
Industry Events |
 |
PPMA Total Show
1-3 October 2019, Birmingham
About PPMA Total Show
PPMA Total is one of UK’s largest processing and packaging
machinery exhibitions. Building on the success of the PPMA Show in 2018,
PPMA Total returns to the NEC, Birmingham, on 1-3 October 2019 for
another show-stopping event.
More info >> |
|
 |
News and Press Releases |
 |
Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations
Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >> |
|
 |
White Papers |
 |
|
High Potency Drugs – from Molecule to Market
PCI Pharma Services
PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any Highly Potent Active Pharmaceutical Ingredients (HPAPI) project. Backed by 30 years’ experience of managing potent molecules, PCI Pharma Services is the logical choice when selecting an outsourcing partner.
More info >> |
|
|
